
As healthcare costs continue to rise, accurate cost-effectiveness estimates are crucial. However, estimating the costs and outcomes of different interventions is complicated by uncertainty.
In model-based health economic evaluations (HEEs), uncertainty can arise from limited data, methodological limitations, and variability in clinical outcomes.
A recent review identified 80 methods for identifying, analyzing, and communicating uncertainty in HEEs. Quantifying uncertainty wherever possible is crucial to ensure accurate and unbiased cost-effectiveness estimates, ultimately leading to optimal allocation of healthcare resources
Recent Posts
Transformative PBM Reform Legislation Signed into Law
PBM Reform Legislation Signed into Law
President Trump signed a comprehensive spending bill incorporating landmark PBM reform legislation, ending a partial government shutdown while targeting pharmacy benefit managers (PBMs) with transformativ...
Advancing Cancer Screening in Slovenia: A Pathway to Equitable Care
Spotlight on Cancer Screening Slovenia at Strategic Conference
Cancer screening Slovenia took center stage at Slovenia’s 6th Strategic Conference "Living with Cancer," held at the National Council of the Republic of Slo...
Disrupting Prescription Drug Pricing: Mark Cuban’s Cost-Plus Vision
Exposing Prescription Drug Pricing Flaws
Prescription drug pricing in the US is riddled with inefficiencies, as revealed in this JAMA interview published online on Febru...